Open NowResearch2026 Post-Acute Sequelae of COVID-19
MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19
National Health and Medical Research Council (NHMRC) · Australia
This Medical Research Future Fund grant opportunity provides funding for research and medical innovation projects focused on post-acute sequelae of COVID-19 (PASC). It supports four research streams covering mechanistic studies, pre-clinical and early-phase clinical research, comparative biological investigations, and large-scale integrated care pathway evaluation with consumer co-design.
Funding
$200K – $3M
Deadline
2 Sept 2026
Duration
up to 2 years for Streams 1-3; up to 5 years for Stream 4
Location
Australia
Who Can Apply
• Applications will only be accepted from approved MRFF Eligible Organisations.
• Applicants must satisfy all requirements in the grant opportunity guidelines.
• Applications must address one of the 4 specified research streams.
• An application may only be submitted to one stream.
• Applications are submitted by the MRFF Eligible Organisation via NHMRC's Sapphire system.
Applications will only be accepted from approved MRFF Eligible Organisations. Applicants must satisfy all requirements set out in the Medical Research Future Fund – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 Grant Opportunity Guidelines. Applications must propose research addressing one of the four specified streams, and an application may only be submitted to one stream. Applicants are advised to liaise with the MRFF Eligible Organisation that will submit the application.
What's Funded
Funded activities include medical research and medical innovation projects investigating biological pathways and mechanistic drivers of PASC subtypes, pre-clinical and early-phase clinical research, small-scale comparative studies, and large-scale evaluation of integrated care pathways. All projects must include meaningful consumer co-design across all stages of research.Expected Outcomes
Expected outcomes include improved understanding of PASC subtypes and mechanisms, evidence to inform pharmacological and non-pharmacological treatments, comparative insights into biological drivers and pathology, and evaluation of effective, feasible, scalable and sustainable integrated care approaches for people with PASC.Key Information
Applicant Types
universitynon_profitother
Stage
any
Funding Purposes
researchinnovation
Keywords
MRFFmedical researchmedical innovationCOVID-19post-acute sequelae of COVID-19PASClong COVIDconsumer co-design
Frequently Asked Questions
1
What is the MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19?
The MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 is a research grant offered by National Health and Medical Research Council (NHMRC) in Australia, providing $200K – $3M in funding. This Medical Research Future Fund grant opportunity provides funding for research and medical innovation projects focused on post-acute sequelae of COVID-19 (PASC). It supports four research streams covering mechanistic studies, pre-clinical and early-phase clinical research, comparative biological investigations, and large-scale integrated care pathway evaluation with consumer co-design.
2
How much funding does the MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 provide?
The MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 provides $200K – $3M in funding. The typical project duration is up to 2 years for Streams 1-3; up to 5 years for Stream 4.
3
Who is eligible for the MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19?
- Applications will only be accepted from approved MRFF Eligible Organisations.
- Applicants must satisfy all requirements in the grant opportunity guidelines.
- Applications must address one of the 4 specified research streams.
- An application may only be submitted to one stream.
- Applications are submitted by the MRFF Eligible Organisation via NHMRC's Sapphire system.
4
When does the MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19 close?
Applications close on 2 Sept 2026.
5
What activities are funded?
Funded activities include medical research and medical innovation projects investigating biological pathways and mechanistic drivers of PASC subtypes, pre-clinical and early-phase clinical research, small-scale comparative studies, and large-scale evaluation of integrated care pathways. All projects must include meaningful consumer co-design across all stages of research.
6
How do I apply for the MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2026 Post-Acute Sequelae of COVID-19?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.